Westport Fuel Systems Inc. (NASDAQ:WPRT) is gaining traction with investors, as evidenced by its 0.85 million shares volume. The daily trading volume average remained 1.31 million shares over the course of 3 months. The stock had opened the regular trading at $3.97 and managed a -2.03% price change to reach $3.87 through the close.Westport Fuel Systems Inc. (WPRT) Analyst Opinion
Westport Fuel Systems Inc. has a consensus outperform rating from 4 Wall Street analysts, and the number of shares currently sold short amount to at least 3.52% of shares outstanding. The stock spiked 41.76% last month and is up 2.93 this year. Wall Street is only getting more bullish on the stock, with 2 of analysts who cover WPRT having a buy-equivalent rating. Analysts have placed a $4.25 price target on Westport Fuel Systems Inc., suggesting a 9.82% gain from recent close. It’s currently trading about -10.62% below its 52-week high.
Westport Fuel Systems Inc. (WPRT) revenue totaled $52.91 million down -14.77% from the previous quarter.Westport Fuel Systems Inc. (NASDAQ:WPRT) Intraday View
This stock (WPRT) is ahead of its 52-week low with 371.95%. Its last month’s stock price volatility remained 7.82% which for the week stands at 7.49%. The share price has moved forward from its 20 days moving average, trading at a distance of 17.56% and stays 20.5% away from its 50 days moving average. Over the last five days, shares have managed 2.93% gains and now is up 65.66% since hitting its 200-day moving average of $2.77. Westport Fuel Systems Inc. (WPRT) has made its way to a 12-month gain of 209.6%.
Turning to Abeona Therapeutics Inc. (NASDAQ:ABEO), its shares were trading at $15.25 a retreat of $-0.4, on the trading floor. The stock, after opening at $15.65, touched a high of $15.707 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.8. Abeona Therapeutics Inc. has 2 buy ratings, 0 holds and 0 sells even after the stock tumbled -32.97% from its high of $22.75 to a $765.7 million market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 1.75 to 1.75 during a month. Analysts set a 12-month price target of $29.09 a share. The target implies a 90.75% spike from where the shares are currently trading. Also, the current price highlights a discount of 129.51% to analysts’ high consensus price target.Abeona Therapeutics Inc. (NASDAQ:ABEO) Intraday Trading
The counter witnessed a trading volume of 0.45 million shares versus an average volume of 1.01 million shares during last trading session. Its last month’s stock price volatility remained 6.77% which for the week approaches 6.75%. The lowest price the stock reached in the last trading day was $15.05 and compares with the $4.50 52-week low. The stock recovered 238.89% since its low point and has performed -3.79% year-to-date.